The Latest Breaking News from Relmada rapeutics

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022

Upgrades

Benzinga · Oct 14, 2022

Relmada Therapeutics Earnings Preview

Relmada Therapeutics (NASDAQ:RLMD) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Relmada Therapeutics will report an earnings per share (EPS) of $-1.27.

Benzinga · May 4, 2022

Here's Why Relmada Therapeutics Shares Are Rising

Relmada Therapeutics Inc (NASDAQ: RLMD) shares are trading higher by 7.2% at $25.01 after the company reported better-than-expected fourth-quarter EPS results.

Benzinga · Mar 24, 2022